Skip to main content
Figure 1 | Radiation Oncology

Figure 1

From: Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size

Figure 1

Curves for (a) overall survival, (b) cause-specific survival, (c) progression-free survival, and (d) local control in stage I NSCLC patients. Solid line, all patients (n = 124); dashed line, stage IA patients treated with 48 Gy in 4 fractions (n = 85); and dotted line, stage IB patients treated with 52 Gy in 4 fractions (n = 37).

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us